WHO ‘Very Likely’ Won’t Approve Medicago’s Covid Vaccine Due To Tobacco Ties
Topline
A plant-based Covid-19 vaccine developed by Canadian pharmaceutical agency Medicago “very doubtless received’t be accepted” for emergency use approval by the World Well being Group as a result of Medicago is partially owned by cigarette producer Philip Morris Worldwide, a WHO official said Wednesday.
Medicago’s Covifenz vaccine could turn out to be the primary Western-manufactured Covid-19 vaccine rejected by … [+]
STR/NurPhoto by way of Getty Photographs
Key Info
Medicago’s utility for emergency use approval has been paused as a result of firm’s connection to Philip Morris, which could run afoul of the WHO’s “very strict” insurance policies on partnering with tobacco and arms firms, Dr. Mariângela Simão, the WHO’s assistant director-general of entry to medicines and well being merchandise, stated.
The vaccine—referred to as Covifenz—could be the primary Western-manufactured Covid-19 shot rejected by the WHO, Bloomberg reported.
Philip Morris holds a 21% stake in Medicago, whereas Japanese pharmaceutical agency Mitsubishi Tanabe owns a 79% stake, a Medicago spokesperson stated.
Medicago CEO Takashi Nagao stated in an announcement Wednesday he had not obtained any official communication from the WHO, and emphasised that the WHO’s resolution was not linked to the protection and efficacy of the corporate’s vaccine.
If Covifenz is rejected by the WHO, the vaccine could be excluded from the COVID-19 Vaccines World Entry (COVAX) initiative, which helps present vaccines and different provides for combating Covid-19 to creating international locations, doubtless curbing worldwide demand for Covifenz.
Earlier this month, the WHO announced it had rejected Medicago’s request to have Covifenz pre-qualified for approval.
Key Background
In October 2020, Medicago agreed to produce as much as 76 million vaccine doses to the Canadian authorities whereas receiving $173 million in authorities funding. Medicago’s Covifenz is the primary plant-based Covid-19 vaccine, and it confirmed 71% effectiveness in opposition to the virus and 75.3% effectiveness in opposition to the delta variant in research performed earlier than the omicron variant grew to become dominant. Well being Canada approved Covifenz to be used by folks ages 18 to 64 on February 24. On the time, Canadian Minister of Innovation, Science and Trade François-Philippe Champagne hailed the drug’s approval as a milestone in reversing a 40-year decline within the nation’s biomanufacturing trade, although Covifenz has but to be authorised to be used anyplace exterior Canada. The WHO’s potential to do enterprise with entities linked to the tobacco trade is proscribed by the 2005 Framework Convention on Tobacco Protocol, which makes an attempt to limit tobacco trade pursuits from influencing healthcare coverage.
Tangent
Canada is a signatory to the Framework Conference on Tobacco Protocol, and its partnership with Philip Morris subsidiary Medicago provoked criticism from some tobacco management teams. “Even when it’s not a violation of the letter, it’s undoubtedly a violation of the spirit of the conference,” Les Hagen, govt director for anti-smoking group Motion on Smoking and Well being in Edmonton, Canada, told Bloomberg. “This isn’t Canada’s proudest second in public well being.”
Additional Studying
“Medicago Covid Shot Faces WHO Rejection Over Company’s Tobacco Links” (Bloomberg)
